BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1651087)

  • 1. Structure and function of retroviral proteases.
    Fitzgerald PM; Springer JP
    Annu Rev Biophys Biophys Chem; 1991; 20():299-320. PubMed ID: 1651087
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases.
    Cameron CE; Grinde B; Jacques P; Jentoft J; Leis J; Wlodawer A; Weber IT
    J Biol Chem; 1993 Jun; 268(16):11711-20. PubMed ID: 8389361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural alignment of retroviral protease sequences.
    Weber IT
    Gene; 1989 Dec; 85(2):565-6. PubMed ID: 2560758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates.
    Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Skalka AM
    J Biol Chem; 1992 May; 267(14):9491-8. PubMed ID: 1315756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
    Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
    J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the pseudo-dyad in retroviral proteinase monomers structural or evolutionary?
    Rao JK; Wlodawer A
    FEBS Lett; 1990 Jan; 260(2):201-5. PubMed ID: 2153583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
    Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
    J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
    Tomasselli AG; Heinrikson RL
    Methods Enzymol; 1994; 241():279-301. PubMed ID: 7854182
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and biochemical studies of retroviral proteases.
    Wlodawer A; Gustchina A
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):16-34. PubMed ID: 10708846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
    Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
    Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of homology modeling of HIV protease.
    Weber IT
    Proteins; 1990; 7(2):172-84. PubMed ID: 2158092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.
    Davis DA; Brown CA; Newcomb FM; Boja ES; Fales HM; Kaufman J; Stahl SJ; Wingfield P; Yarchoan R
    J Virol; 2003 Mar; 77(5):3319-25. PubMed ID: 12584357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis.
    Kent SB; Baca M; Elder J; Miller M; Milton R; Milton S; Rao JK; Schnölzer M
    Adv Exp Med Biol; 1995; 362():425-38. PubMed ID: 8540353
    [No Abstract]   [Full Text] [Related]  

  • 14. X-ray structures of retroviral proteases and their inhibitor-bound complexes.
    Ringe D
    Methods Enzymol; 1994; 241():157-77. PubMed ID: 7854176
    [No Abstract]   [Full Text] [Related]  

  • 15. A structural model for the retroviral proteases.
    Pearl LH; Taylor WR
    Nature; 1987 Sep 24-30; 329(6137):351-4. PubMed ID: 3306411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations that alter the activity of the Rous sarcoma virus protease.
    Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Bizub D; Skalka AM
    J Biol Chem; 1992 May; 267(14):9481-90. PubMed ID: 1315755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of substrate residues on the P2' preference of retroviral proteinases.
    Boross P; Bagossi P; Copeland TD; Oroszlan S; Louis JM; Tözsér J
    Eur J Biochem; 1999 Sep; 264(3):921-9. PubMed ID: 10491141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.
    Konvalinka J; Horejsí M; Andreánsky M; Novek P; Pichová I; Bláha I; Fábry M; Sedlácek J; Foundling S; Strop P
    EMBO J; 1992 Mar; 11(3):1141-4. PubMed ID: 1547777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of a retroviral protease proves relationship to aspartic protease family.
    Miller M; Jaskólski M; Rao JK; Leis J; Wlodawer A
    Nature; 1989 Feb; 337(6207):576-9. PubMed ID: 2536902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.
    Wlodawer A; Miller M; Jaskólski M; Sathyanarayana BK; Baldwin E; Weber IT; Selk LM; Clawson L; Schneider J; Kent SB
    Science; 1989 Aug; 245(4918):616-21. PubMed ID: 2548279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.